Drawtex®, First Product in Portfolio, Launched Today at Wounds UK Conference
New alcohol and chloroform free formulation expected in pharmacies mid to late November.
Extends Critical Care Caffeine range with launch of oral product to improve ease of use.
Martindale Pharma is pleased to announce that the Company has joined the Sunday Times Deloitte Buyout Track 100, as one of the top 100 fastest growing private equity backed companies in 2012
Martindale Pharma is pleased to announce the launch today of Latanoprost 0.005% w/v eye drop solution (2.5ml solution), a first in line treatment for Glaucoma